(Q47996302)

English

Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders

scientific article published on 9 July 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

Alzheimer's disease

0 references

cerebrospinal fluid

0 references

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

Henrik Zetterberg

2

object named as

Henrik Zetterberg

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

6

object named as

Kaj Blennow

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

Elisabet Londos

3

object named as

Elisabet Londos

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

Lennart Minthon

4

object named as

Lennart Minthon

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

Katarina Nägga

5

object named as

Katarina Nägga

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

1

object named as

Magdalena Nutu

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

author name string

Annika Ohrfelt

8

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

publication date

9 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

Dementia and Geriatric Cognitive Disorders

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

36

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

1-2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

99-110

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Evidence that Aβ42 is the real culprit in alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Has the amyloid cascade hypothesis for Alzheimer's disease been proved?

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Diagnostic criteria for Parkinson disease

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Clinical diagnostic criteria for dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Development of homogeneous 384-well high-throughput screening assays for Abeta1-40 and Abeta1-42 using AlphaScreen technology

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Cerebrospinal fluid protein biomarkers for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta42(43).

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.

1 reference

https://api.crossref.org/works/10.1159%2F000353442

21 January 2018

Identifiers

10.1159/000353442

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

release_7zczs2zwsfennez5i2yhdyfuay

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/23860354

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47996302&oldid=2180969413"